Perspective Therapeutics CATX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $53.97M+21.5% | $30.63M-50.3% | $26.76M-88.2% | $28.85M-88.6% | $44.41M-68.8% | ||
| $216.96M+29.7% | $114.11M-31.0% | $147.38M+256% | $162.73M— | $167.3M— | ||
| —— | —— | —— | $0-100% | $0-100% | ||
| $58K-25.6% | $6K-94.8% | $179K-17.5% | $225K+58.5% | $78K-92.2% | ||
| $4.37M+10.2% | $3.65M-11.7% | $4.18M+98.5% | $4.16M+239% | $3.96M+208% | ||
| $275.35M+27.6% | $148.39M-35.8% | $178.5M-33.9% | $195.96M-33.4% | $215.74M+14.6% | ||
| $92.48M+51.0% | $76.6M+33.6% | $64.35M+46.9% | $62.6M+324% | $61.25M+328% | ||
| $2.44M+22.6% | $1.5M-32.3% | $1.54M-36.9% | $1.77M-12.5% | $1.99M+88.5% | ||
| —— | —— | —— | —— | —— | ||
| $40M-20.0% | $40M-20.0% | $50M0.0% | $50M0.0% | $50M0.0% | ||
| $490K+33.9% | $486K+20.0% | $438K-36.9% | $401K-40.3% | $366K-24.1% | ||
| $410.77M+24.7% | $266.97M-21.7% | $294.83M-24.6% | $310.73M-19.5% | $329.35M+18.3% | ||
| $26.49M+203% | $20.51M+98.3% | $13.15M-39.7% | $7.05M+15.0% | $8.73M+44.9% | ||
| $3.88M+33.1% | $7.49M— | $6.71M— | $5.04M— | $2.91M— | ||
| $1.07M+9.1% | $623K-34.9% | $704K-22.0% | $847K+17.6% | $980K+666% | ||
| —— | —— | —— | —— | —— | ||
| $31.49M+148% | $28.68M+57.3% | $20.62M-26.7% | $12.99M+22.4% | $12.68M-12.6% | ||
| $1.55M-3.5% | $1.57M-3.4% | $1.58M-3.4% | $1.6M-3.3% | $1.61M-3.1% | ||
| $1.55M+32.2% | $1.01M-29.6% | $971K-42.1% | $1.07M-26.1% | $1.17M+13.2% | ||
| $2.62M+21.7% | $1.63M-31.7% | $1.68M-35.1% | $1.92M-11.6% | $2.15M+84.9% | ||
| $437K+201% | $386K— | $342K— | $284K— | $145K— | ||
| $63.33M+41.7% | $59.94M+18.9% | $52.61M-16.1% | $45.03M+0.2% | $44.7M-7.6% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $114K+56.2% | $74K+5.7% | $74K+10.4% | $74K+10.4% | $73K-87.6% | ||
| $708.58M+32.6% | $541.69M+3.7% | $539.38M+3.7% | $537M+3.8% | $534.45M+35.6% | ||
| -$361.03M-44.5% | -$334.84M-44.5% | -$297.35M-55.2% | -$271.38M-53.8% | -$249.9M-51.7% | ||
| -$226K— | $110K— | $114K— | —— | —— | ||
| $347.44M+22.1% | $207.03M-28.8% | $242.22M-26.3% | $265.69M-22.1% | $284.65M+23.8% | ||
| $410.77M+24.7% | $266.97M-21.7% | $294.83M-24.6% | $310.73M-19.5% | $329.35M+18.3% | ||
| $490K+33.9% | $486K+20.0% | $438K-36.9% | $401K-40.3% | $366K-24.1% | ||
| $40M-20.0% | $40M-20.0% | $50M0.0% | $50M— | $50M— | ||
| $40M-20.0% | $40M-20.0% | $50M0.0% | $50M— | $50M— | ||
| $40M-20.0% | $40M-20.0% | $50M0.0% | $50M— | $50M— | ||
| $40M-20.0% | $40M-20.0% | $50M0.0% | $50M— | $50M— | ||
| $2.44M+22.6% | $1.5M-32.3% | $1.54M-36.9% | $1.77M-12.5% | $1.99M+88.5% | ||
| $2.44M+22.6% | $1.5M-32.3% | $1.54M-36.9% | $1.77M-12.5% | $1.99M+88.5% | ||
| $490K+33.9% | $486K+20.0% | $438K-36.9% | $401K-40.3% | $366K-24.1% | ||
| $216.96M+29.7% | $114.11M-31.0% | $147.38M+256% | $162.73M+298% | $167.3M+334% | ||
| $2.44M+22.6% | $1.5M-32.3% | $1.54M-36.9% | $1.77M-12.5% | $1.99M+88.5% | ||
| $490K+33.9% | $486K+20.0% | $438K-36.9% | $401K-40.3% | $366K-24.1% | ||
| $3.88M+33.1% | $7.49M— | $6.71M— | $5.04M— | $2.91M— | ||
| $26.49M+203% | $20.51M+98.3% | $13.15M-39.7% | $7.05M+15.0% | $8.73M+44.9% | ||
| $3.88M+33.1% | $7.49M— | $6.71M— | $5.04M— | $2.91M— | ||
| $56K+5.7% | $56K+7.7% | $55K+7.8% | $54K— | $53K— | ||
| $56K+5.7% | $56K+7.7% | $55K+7.8% | $54K— | $53K— | ||
| $4.18M+10.9% | $3.2M-20.3% | $3.26M-22.7% | $3.52M-8.0% | $3.77M+33.1% | ||
| $708.58M+32.6% | $541.69M+3.7% | $539.38M+3.7% | $537M+3.8% | $534.45M+35.6% | ||
| $114K+56.2% | $74K+5.7% | $74K+10.4% | $74K+10.4% | $73K-87.6% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $26.6M0.0% | $26.6M0.0% | $26.6M0.0% | $26.6M— | $26.6M— | ||
| $1.7M-31.8% | $1.7M-31.8% | $2.5M-45.7% | $2.5M— | $2.5M— | ||
| $40M-20.0% | $40M-20.0% | $50M0.0% | $50M— | $50M— | ||
| $1.55M-3.5% | $1.57M-3.4% | $1.58M-3.4% | $1.6M-3.3% | $1.61M-3.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Perspective Therapeutics's total assets?
- Perspective Therapeutics (CATX) holds $410.8M in total assets, up 24.7% year over year.
- How much debt does Perspective Therapeutics have?
- Perspective Therapeutics carries $4.2M in total debt against $347.4M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Perspective Therapeutics have?
- Perspective Therapeutics holds $54.0M in cash and equivalents.
- Can Perspective Therapeutics cover its short-term obligations?
- Its current ratio is 8.75 — current assets exceed current liabilities.
- Where does Perspective Therapeutics's balance sheet data come from?
- Every line is extracted from Perspective Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
